INTRODUCTION
Despite limitation, measurement of central venous pressure (CVP) remains valuable when used in concert with clinical examination in guiding manipulation of circulating volume status. [1] Given the inherent risks associated with central venous catheterization, however, CVP monitoring has largely remained confined to the critically unwell. Recent reports of alternative modalities for obtaining CVP estimation [2] [3] [4] [5] hold promise for utilization of fi lling pressure estimation in volume state assessment both prior to central line insertion and in those patients in whom central line placement is deemed unnecessary.
Peripherally acquired venous pressure (PVP) has additionally been demonstrated to correlate with CVP in a number of studies in the operating theatre [6] [7] [8] [9] [10] and intensive care settings. [11] If demonstrated reliable, utilization of PVP in clinical volume status assessment holds the obvious advantage of widespread potential application as almost all patients admitted to hospital undergo peripheral venous cannulation. To be clinically useful, however, any such estimate of CVP must prove accurate across a breadth of CVP recordings in a wide range of pathologic conditions. Understanding of factors that may influence PVP/CVP correlation during conditions of extreme CVP values (i.e. very low, or very high CVP recordings) is therefore essential as these factors are most likely to result in manipulations of cardiac preload by clinicians.
We have previously demonstrated a greater correlation between PVP and CVP at higher CVP values, [12] citing a direct influence of the compressive effect of tissue pressure on the observed relationship between PVP and CVP. Specifically we hypothesized lesser difference between values when intervening conduit resistance was least, affording unimpeded flow. We further postulated this to correspond with an intraluminal pressure above which the propensity for tissue pressure to induce vascular collapse is negated.
The present investigation was therefore conducted to further explore the infl uence of tissue pressure on the relationship between central and peripherally acquired venous pressure metrics. Both in vitro and en vivo models were utilized. A bench-top model of the venous circulation of the upper limb was initially interrogated to document the effect of increasing tissue pressure on PVP/CVP correlation. In the second phase of the study CVP/PVP parings were acquired in a solitary human subject undergoing mimicked tissue pressure elevation via external cuff, and Valsalva induced variation of CVP.
METHODS
This investigation utilized both in vitro and en vivo models of peripheral/central venous pressure correlation to explore the relationship between the two variables. Details of experimental set-up and data acquisition for both methodologies are outlined below.
In vitro model-experimental set-up
A mechanical model was constructed mimicking the venous circulation from the antecubital fossa to the confl uence of the subclavian and internal jugular veins of the upper limb. In brief, this consisted of a 45 cm length of 7.5 mm internal diameter thin walled deformable latex tubing as a surrogate for the venous conduit, supported within a rigid water-filled transparent bath mimicking surrounding soft tissues. The "vein" was manufactured to include two internal one-way "fish-mouth" valves positioned at equal intervals as per human anatomy. The apparatus was "perfused" with two automated flow generators (IPX1 infusion pump, Cardinal Health, Rolle, Switzerland) connected in parallel and capable of providing from 0 to 2000 mL/h continuous flow. Luminal pressure at both ends of the apparatus with a 35 cm water manometer connected by 3-way tap to the distal (nominally PVP) and proximal (nominally CVP) ends of the tubing respectively. Adjustment of the height (H) of the perfuslate outflow served to provide varying CVP pressures. Pressure within the surrounding waterbath (nominally tissue pressure[TP]) was controlled via graded injection of fluid, and assessed by an identical water fi lled manometer attached to the bath. A schematic of the experimental set-up is presented in Figure 1 .
Data collection
The experimental apparatus was perfused with 0.9% saline solution at constant rate (1000 mL/h and 2000 mL/h) during phase one and two of acquisition of study metrics respectively. For both flow rates, CVP/ PVP parings were obtained at three differing tissue pressure settings (0 cmH 2 O, 10 cmH 2 O, and 20 cmH 2 O). Each venous pressure recording was made two minutes after adjustment of CVP height. Pressure metrics were recorded to the nearest one mm. All data-points were obtained in triplicate and mean values reported.
En vivo model-experimental set-up
Ethical approval for the en vivo model was sought and gained from the Northern Y division of the New Zealand Health and Disability Ethics Committees. A single volunteer (MH) underwent venous cannulation of the antecubital fossa vein (PVP) and external jugular vein (CVP) with18G intravascular cannulae (Becton Dickinson Infusion Therapy Systems Inc, Utah, USA) on the right. These were connected via Truwave pressure transducers (Edwards Lifesciences, Irvine, CA, USA) to a Phillips IntelliVue MP50 (Boeblingen, Germany) and a bedside monitor for assessment of venous pressure metrics. The pressure transducers were room air zerocalibrated with reference to the mid thorax. The subject remained in supine, with the arm in the mid-thoracic position, for the duration of the experimental protocol.
Following instillation of 1 mL 1% lignocaine solution, one 22G needle was inserted to a depth of 1.5 cm overlying the central biceps on the right for assessment of tissue pressure. One mL of 0.9% saline solution was injected, and the needle connected via an identical pressure transducer to the monitoring system. This transducer was likewise room air zero-calibrated with reference to the mid thorax. Following taping, a standard sphygmomanometer blood pressure cuff was centred over the sampling needle and applied. Tissue pressure was thereby able to be manipulated by inflating the blood pressure cuff to a predefined tissue pressure, and clamping the attached pneumatic tubing. A thirty-minute stabilization was afforded before acquisition of study parameters.
Data collection
While positioned in supine, the subject performed graded Valsalva manouvres (against closed glottis only) to a constant CVP value. Repeated pared CVP/PVP recordings were obtained following maintenance of a stable CVP for a period of 10 seconds across a range of CVP levels. Acquisition of venous pressure recordings was repeated at three different tissue pressure settings (native[cuff deflated], 10 mmHg, and 20 mmHg). Pressure metrics was taken as a time-weighted average of venous pressure waves as per the manufacturer software. All pressures were recorded to the nearest mmHg.
Statistical analysis
Statistical analysis of all variables was conducted using GraphPad Prism (version 5.0, La Jolla, CA, USA). Simple linear regression was used to observe the relationship between PVP and CVP values for both models. In each case (in vitro/en vivo models, and for individual fl ow rates in the in vitro model) the slope of linear regression was compared for grouped venous pressure values below (and inclusive) and above the nominated tissue pressure level. Goodness of fi t for each was assessed using the r 2 statistics. Bland-Altman plots were constructed to assess limits of agreement between PVP and CVP for the en vivo model.
RESULTS
Ve n o u s p r e s s u r e c o r r e l a t i o n a n d P V P / C V P differential according to tissue pressure for flow rates 1000 mL/h and 2000 mL/h in the in vitro model are presented graphically in Figure 2 . Linear regression slopes for this model and goodness of fi t are presented in Table 1 (0 cm water grouping not differentiated).
Venous pressure correlation and PVP/CVP differential according to tissue pressure for the en vivo model are presented graphically in Figure 3 . Bland-Altman plots of the en vivo data are presented in Figure 4 . Linear regression slopes for this model and goodness of fit are presented in Table 2 (6 mmHg grouping not differentiated). While the finding of accurate PVP/CVP correlation was reported in numerous series, [6] [7] [8] [9] [10] few investigators have sought to quantify factors associated with lesser agreement between these variables. Greater PVP-CVP differential at low absolute CVP values has been reported by Hoftman et al [6] in nine patients undergoing orthotopic liver transplantation. Similarly we have found a greater PVP/CVP correlation in high CVP values, with increased PVP/CVP divergence at lower absolute CVP values in 34 adult patients undergoing elective cardiac surgery. [12] The explanation forwarded by both authors to explain this phenomenon was collapse of peripheral venous conduits during the period of low intraluminal pressure, thereby obscuring an intact fl uid column from central to peripheral monitoring sites. Such a classic "vascular waterfall" effect may in large part explain the results of the current study. Notably, 'vessel' collapse was observed to occur visually in the in vitro model during investigation at higher tissue pressures, with complete 'vessel' expansion noted following CVP elevation above tissue pressure in all instances of data acquisition.
The implications of these findings are of potential clinical relevance. Any utilization of PVP in volume state assessment must include consideration for tissue pressure elevation to effect elevaed and erroneous PVP recordings relative to true CVP. Given greatest PVP-CVP differential has been observed at low CVP values, and with higher tissue pressures, greatest potential for clinical inaccuracy exists in patients with genunine hypovolaemia (and therefore reduced cardiac filling pressures). Unfortunately, this population represents a subgroup of patients wherein accurate knowledge of CVP might conceivably result in appropriate clinician directed action to undertake preload enhancement with infusion of circulatory volume expanders.
The clinician undertaking PVP assessment as a surrogate for CVP must therefore ensure all practical steps are taken to minimize the effect of external pressure (limb positioning, constricting gowns, leaning surgeons) on the limb between the sites of peripheral cannulation and the thorax. Additionally, while likely to remain unmeasured, consideration of the likelihood of elevated tissue pressure (peripheral edema, traumatic insult, ischemia) may assist in interpretation of acquired PVP metrics. Notably, early investigators reported subcutaneous tissue pressures between zero and eight cmH 2 O in the forearm and leg for normal individuals, and exceeding 20 cmH 2 O in edematous patients. [13] The framework in which these results are viewed may additionally provide insights into the management of the circulation. CVP is often used in assessment of the volume state. That (venous pressure -tissue pressure) rather than venous pressure alone is the determinant of venous volume may in part explain the variability in usefulness of this measure. Additionally, the role of tissue pressure in impeding venous return may be underappreciated clinically. The venous return equation is as follows: Cardiac output = (mean systemic filling pressure -CVP/resistance of the average circulatory element). Much of the circulatory volume exists in the veins, increasing the contribution of this compartment to resistance of the average element. Venous collapse secondary to tissue pressures within the range caused by edema could impede venous return. A "vicious circle" of overfilling leading to edema leading the need for more fl uid could be hypothesized.
This study has a number of methodologic limitations inherent to the interrogated models utilized in this work. The in vitro model utilized presents a 'static' representation of the dynamic human circulation. Variability in venous return secondary to alteration in vascular tone, cardiac index, and the respiratory cycle has not been replicated. Furthermore, the model was perfused with 0.9% saline solution, rather than a fluid more accurately mimicking the fl ow dynamics of human blood. While the presented results nevertheless demonstrate a good approximation of those observed in the en vivo model, we are unable to comment on the potential for differing patterns of flow associated with more viscous fluids to alter observed pressure metrics. Interpretation of the results of the en vivo model are constrained by the use of external jugular pressure as a surrogate for true CVP. While there is some evidence suggesting that external jugular pressure is correlated well with centrally acquired venous pressure, [14, 15] we have failed to include central venous cannulation and true CVP estimation in this protocol. The risks associated with central venous cannulation were, however, considered in excess of those appropriate for such a volunteer study. The en vivo model furthermore containsed no measure of venous flow rate in the studied limb. Data from the in vitro model would nevertheless suggest a similar relationship between the two variables irrespective of blood velocity.
A greater correlation between peripherally acquired venous pressure and central venous pressure was demonstrated when absolute CVP exceedsed tissue pressure in the in vitro and en vivo models utilized in this study. Clinical utilization of PVP in volume status assessment must depend upon the potential for elevated tissue pressure to obscure accurate PVP estimation of CVP, at low absolute CVP values.
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